Gabapentin Tablet, Film Coated
Product Images NDC 71335-1026

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
This is a formula to calculate the creatinine clearance (CLCr) of patients based on their age, weight, and serum creatinine levels. The formula is adjusted for female patients by multiplying the result by 0.85.*
FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
This data presents information on the mean pain score for a 4-week fixed dose period. The study involved the use of Gabapentin, with a dosage of 1800 mg/day for one group and 2400 mg/day for another group. The placebo group is also mentioned. However, there is no further information on the study design or outcomes.*
FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
This is a statistical analysis of controlled PHN studies. The data in figure 3 shows the percentage of patients who responded to treatment, with a pain score reduction of more than 50%, at the end of the study. Study 2 had a slightly higher percentage of responders at 34%, compared to Study 1 which had 32%. The text also includes some monetary values, GBP 3600, GBP 1800 and GBP 2400, likely representing costs associated with the study.*
FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

FDA Label Image

Label (Lbl713351026)

Label (Lbl713351026)
This text appears to be a medication label containing information such as the brand name, the dosage, manufacturer, expiration date, and storage instructions. It also includes a warning to keep the medication out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.